FUJIFILM intends to accelerate production of Avigan to 100,000 treatment courses per month by July and up to 300,000 by September 2020 to meet demand for possible use treating COVID-19.
List view / Grid view
Avigan® Tablet (favipiravir)
Filter the results
The developers of Avigan have increased production and announced a Phase III clinical trial testing its efficacy against COVID-19.